10/22: Virtual Annual Meeting Kick-Off - A Conversation with Director Iancu

Join AIPLA President Barbara Fiacco for a conversation with the Honorable Andrei Iancu, Under Secretary of Commerce for Intellectual Property and Director of the USPTO as we welcome attendees to the first ever AIPLA Virtual Annual Meeting.

With thanks to the AIPLA Professional Programs Committee, coordinators, moderators, and speakers for helping put together these incredible CLE programs, and the AIPLA’s Committee Leadership and Sponsors for hosting a number of virtual networking meet ups, programs, happy hours, and other sessions.

We’re excited for an engaging fun 8 days, as we all connect from our remote locations, around the globe. If you miss a session, don’t worry. If you have the Full Meeting Package, you will have access to all of the recordings for every CLE session. Individual sessions remain available if you’d prefer to pick and choose sessions.

This session is not CLE accredited

Speakers

• Iancu, Andrei

  Sullivan & Cromwell | Partner

  Andrei Iancu was first an aerospace engineer at Hughes Aircraft, then a premier patent trial lawyer, later serving as Under Secretary of Commerce for Intellectual Property and Director of the USPTO. He is presently a litigation partner at Sullivan & Cromwell and a leading voice on IP policy. With David Kappos, he founded the Council for Innovation Promotion (C4IP) and, with former NIST Director Walter Copan, founded the Renewing American Innovation project at the Center for Strategic and International Studies (CSIS).
• Fiacco, Barbara A.

  Foley Hoag, LLP | Co-Chair, Patent Litigation Practice

  Barbara Fiacco is a Partner, co-chair of the Intellectual Property Department and co-chair of the Patent, Trade Secrets, and Related Rights Litigation Practice at Foley Hoag LLP. In her practice, Barbara handles complex intellectual property and business disputes in the life sciences industry. She has successfully litigated patent, trade secret, and inventorship disputes for global pharmaceutical and biotechnology companies, medical device manufacturers and research institutions.